Research funder · United States
Alzheimer's Association
A non-profit American health organization which focuses Alzheimer's disease
- Grants since 2016
- 1 779
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 7 372
- Funded works, all time
- 14.6k
Grants
2026 · research · AARG
Multimodal biomarkers to establish disease modification in AD
Philip Insel · University of California, San Francisco
2026 · research · AARG
ApoE4 reduces neurogenesis during brain development
Abhisek Mukherjee · The University of Texas Health Science Center at Houston
2026 · research · ZEN
Unlocking Cerebrovascular Drivers of Neurodegeneration
Katerina Akassoglou · Gladstone Institute Of Neurological Disease/university Of California
2026 · research · BFDN
Neurotransmitter-based modifiers of tau aggregation
Paul Seidler · University of Southern California
2026 · research · PTC
Aquinnah Pharmaceuticals Tauopathy Therapeutic AQV-8741: A Phase I Study
Glenn Larsen · Aquinnah Pharmaceuticals Inc
2026 · research · AACSF
Unmasking Neurodegeneration in Psychiatric Inpatients
Nahuel Magrath Guimet · Instituto De Investigaciones Neurologicas Raul Carrea (fleni) (raul Carrea Neurological Research Institute (fleni))
2026 · research · PTC-EMT
Discovery of novel epigenetic inhibitors for Alzheimer’s disease
Can Zhang · Massachusetts General Hospital
2026 · research · BFDN
Reversal of Tau Pathology to Rescue Serotonergic Function in Early AD
Louis Kolling · University of Florida
2026 · research · BFDN
Verified Fair Models for Predicting Progression in Alzheimer's Disease
Chenxi Yuan · New Jersey Institute of Technology
2026 · research · AACSF
Economic Instability, Epigenetic Aging, and VCID Across the Lifecourse
Michelle Caunca · Regent University
2026 · research · PTC-EMT
Novel small molecule EPHB3 inhibitors to prevent AD synapse loss
Evan Lebois · Violet Therapeutics
2026 · research · PTC-EMT
Aged CCD Field Trial for Go-no-go Decision of NNI-362 Ph2 POC Trial
Judith Kelleher-Andersson · Neuronascent, Inc.
2026 · research · AARF
Global Evidence on Menopause and Cognition and Blood-based ADRD Biomarkers
Muqi Guo · Regent University
2026 · research · AARF
Occupational Experiences and Late-Life Brain and Cognitive Health
Liliana Paloma Rojas Saunero · The Regents Of The University Of California, Los Angeles
2026 · research · ZEN
Contribution of Microvascular Alterations to Tau Pathology in AD and CTE
Ann Mckee · Boston University
2026 · research · AARF
Advancing Gene Therapy via novel BBB-penetrant AAV delivery for MAPT-FTD
Can Wang · Regent University
2026 · research · AARF
Microglial Regulation of Vascular and Cognitive Dysfunction in AD
Evangelia Paouri · Cleveland Clinic
2026 · research · AARG
Investigating the Tau-LRP1 complex as a mediator of neuroinflammation
Jennifer Rauch · University of Massachusetts Amherst
2026 · research · PTC
IL-2 plus GLP-1 RA Combination Therapy to Target Inflammation in AD
Alireza Faridar · Methodist Hospital
2026 · research · AARG
Gene-Environment Synergy: Circadian and Metabolic Triggers in MAPT-GR Mice
Juan Palavicini · The University of Texas at San Antonio Health Science Center
2026 · research · AARF
Procoagulant Risk & Intervention: Mechanisms to reduce ARIA (PRIMA-AD)
Marta Casquero-Veiga · Instituto de Investigación Sanitaria Fundación Jiménez Díaz
2026 · research · BFDN
Insulin as a molecular mediator of the cognitive protection of exercise
Elizabeth Rhea · Seattle Institute for Biomedical and Clinical Research
2026 · research · AARF
Does astrocyte-synapse contact regulate synapse removal by microglia in AD?
Travis Faust · University of Massachusetts Chan Medical School
2026 · research · BFDN
Understanding Oligodendrocyte Lineage Dyshomeostasis during Aging and AD
Tsai-Yi Lu · University of Virginia
2026 · research · AARG
Brain-region Selective Axonal Vulnerability as a new target in AD
Edoardo Moretto · Institute Of Neuroscience
2026 · research · PTC
Vortioxetine to improve synaptic connectivity
Terry Goldberg · Research Foundation For Mental Hygiene, Inc. At New York State Psychiatric Institute
2026 · research · PTC-GENE
Small Molecule TREM2 Agonism: Phase 1 and Observational Studies in Early AD
Rita Balice-Gordon · Muna Therapeutics Aps
2026 · research · AARF
Impact of ApoE on epicenter-driven spreading networks of AD pathology
Elisenda Bueichekú · Yale University
2026 · research · AARG
Targeting Sleep and Slow-Wave Activity to Enhance Cognition in MCI
Hyun Kim · Research Foundation For Mental Hygiene, Inc. At New York State Psychiatric Institute
2026 · research · BFDN
Understanding hippocampal circuits during perimenopause in AD mice
Holly Hunsberger · Rosalind Franklin University of Medicine and Science
2026 · research · AACSF
Neuronal changes during healthy aging and Alzheimers in human neurons
Eva Klinman · Washington University in St. Louis
2026 · research · BFDN
Neuroimmune Modulation in Alzheimer's Disease and Related Dementia
Feng Tian · Beth Israel Deaconess Medical Center
2026 · research · BFDN
Health Information Exchange and Emergency Care Quality for People with ADRD
Sunny Lin · Washington University in St. Louis
2026 · research · AARG
Developing a decision-making resource about anti-amyloid therapies
Elyse Couch · Brown University
2026 · research · AARG
Cortical microstructural markers for clinical trials
Nicola Spotorno · Lund University
2026 · research · AARF
Digital cognitive screening to address rural dementia health disparities
Caroline Nester Rooney · Rhode Island Hospital
2026 · research · BFDN
Neurovascular Contributions to Post-ICU Cognitive and Mental Decline
Brandon Yates · Massachusetts General Hospital
2026 · research · AARG
Multi-Omic Links Between Reproductive Aging and AD Risk Among Midlife Women
Justina Avila-Rieger · Columbia University Irving Medical Center
2026 · research · AARF
Uncovering Molecular Regulators of Microglia-Mediated Synapse Loss in AD
Sonia Lombroso · Regent University
2026 · research · AARF
Sexual and Gender Minorities and ADRD
Addam Reynolds · University of Southern California